Eyefinity vs Becton Dickinson

Side-by-side comparison of AI visibility scores, market position, and capabilities

Becton Dickinson leads in AI visibility (79 vs 73)
Eyefinity logo

Eyefinity

LeaderHealthtech

Optometry Practice Management

Optometry and optical PMS owned by VSP Global, serving independent eyecare practices across the US. Rancho Cordova CA; OfficeMate covers scheduling, billing, and EHR; iMedicWare handles optical point-of-sale and lab orders;

AI VisibilityBeta
Overall Score
B73
Category Rank
#98 of 596
AI Consensus
76%
Trend
stable
Per Platform
ChatGPT
76
Perplexity
69
Gemini
76

About

Eyefinity is a Rancho Cordova, California-based optometry and optical practice management software company owned by VSP Global, the largest vision care benefits plan in the United States. Eyefinity provides practice management, electronic health records, and optical lab connectivity tools specifically designed for independent optometrists and optician-led optical retail businesses. The company's products include OfficeMate for practice scheduling, billing, and medical records; ExamWRITER for clinical charting and electronic prescriptions; and iMedicWare for optical point-of-sale and lab order management. Eyefinity's products are used by tens of thousands of eye care professionals across the U.S., many of whom are part of the VSP network of independent optometrists.\n\nEyefinity's connection to VSP Global gives it several advantages in the independent optometry market. VSP's vision care network includes a large proportion of independent optometrists who are naturally inclined toward Eyefinity software because of the seamless VSP insurance eligibility verification and claim submission integration that simplifies the billing workflow for VSP patients—which constitute a significant portion of most private-practice optometry patient volumes. This network integration effectively makes Eyefinity the path of least resistance for VSP-affiliated optometrists seeking practice management software, creating a built-in distribution advantage.\n\nEyefinity has been modernizing its product portfolio through cloud-based offerings and improved user interfaces as competitive pressure from newer optometry software entrants increases. The company competes with Compulink Healthcare Solutions, Revolution EHR, and Crystal Practice Management in the optometry practice management market. Eyefinity differentiates on its VSP integration depth, its large installed base in the VSP network, and the operational trust that comes from being backed by the dominant vision care benefits plan in the United States.

Full profile
Becton Dickinson logo

Becton Dickinson

LeaderHealthcare Tech

Enterprise

Franklin Lakes NJ medical technology (NYSE: BDX) at $21.8B FY2025 revenue (+8.2%); $17.5B Reverse Morris Trust spinoff with Waters (2025), Edwards critical care acquisition $4.2B (2024) competing with Baxter for infusion systems.

AI VisibilityBeta
Overall Score
B79
Category Rank
#25 of 596
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
76
Perplexity
82
Gemini
84

About

Becton, Dickinson and Company (BD) is a Franklin Lakes, New Jersey-based global medical technology company — publicly traded on the New York Stock Exchange (NYSE: BDX) as an S&P 500 Health Care component — manufacturing and selling medical supplies, devices, laboratory equipment, and diagnostic products through approximately 74,000 employees serving healthcare institutions, clinical laboratories, pharmaceutical companies, and life science researchers in over 190 countries. In fiscal year 2025 (ended September 30, 2025), BD reported full-year revenue of $21.8 billion (up 8.2% year-over-year) with Q4 FY2025 revenue of $5.9 billion (+8.3% reported, +3.9% organic growth), and declared a quarterly dividend of $1.05 per share (+1%). Founded in 1897 in New York City by Maxwell Becton and Fairleigh Dickinson Sr. as a thermometer and surgical instrument maker, BD has grown through 125+ years of acquisitions to become a Fortune 500 ($21.8B revenue, #211 on 2024 Fortune 500) global medtech leader. The company operates through three segments: BD Medical (~50% of revenue, IV catheters, syringes, prefillable drug delivery systems, and medication management solutions), BD Life Sciences (flow cytometry, microbiology, molecular diagnostics, and lab automation), and BD Interventional (advanced patient monitoring, interventional cardiology, and peripheral vascular interventions). BD invests $1.2+ billion annually in R&D. In 2024, BD acquired Edwards Lifesciences' critical care monitoring unit for $4.2 billion.

Full profile

AI Visibility Head-to-Head

73
Overall Score
79
#98
Category Rank
#25
76
AI Consensus
77
stable
Trend
stable
76
ChatGPT
76
69
Perplexity
82
76
Gemini
84
72
Claude
84
79
Grok
77

Key Details

Category
Optometry Practice Management
Enterprise
Tier
Leader
Leader
Entity Type
product
company

Capabilities & Ecosystem

Capabilities

Only Eyefinity
Optometry Practice Management

Integrations

Only Becton Dickinson
Eyefinity is classified as product. Becton Dickinson is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.